Inhibition of Functional and Immunological Responses to Thyroid-Stimulating Antibodies from Patients with Graves' Disease by Blockade of the Thyrotropin Receptor
- 1 January 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 3 (4) , 273-278
- https://doi.org/10.1089/thy.1993.3.273
Abstract
Thyrotropin (TSH) receptor is the main autoantigen and the target of thyroid-stimulating antibodies in Graves' disease. In the present studies, in order to shed further light on the role of TSH receptor in thyroid autoimmune disease, we investigated the effects of TSH receptor blockade on functional and immunological responses to thyroid stimulation by Graves' immunoglobulins in the nude mouse bearing human thyroid transplants. Injecting the nude mice with purified Graves' immunoglobulins G resulted in a dose-dependent stimulation of thyroid hormone production, an inducement of cellular hypertrophy of transplant thyrocytes, and an expression of the HLA-DR antigen by up to 75% of the transplant thyroid follicular cells. Treatment of the animals with the TSH receptor antagonist asialoagalacto-hCG was able to inhibit the stimulation by Graves' immunoglobulins G of thyroxine production, cellular hypertrophy of transplant thyrocytes, and HLA-DR expression by thyroid follicular cells in the human transplants. The present data provide direct evidence for an involvement of the human TSH receptor in mediating both the functional disturbance (hyperthyroidism) and the immunological disorder in Graves' disease and add further support to the concept of using TSH receptor antagonists in the management of the disease.Keywords
This publication has 27 references indexed in Scilit:
- The thyrotropin receptor and the regulation of thyrocyte function and growthEndocrine Reviews, 1992
- Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo.Journal of Clinical Investigation, 1991
- Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patientsBiochemical and Biophysical Research Communications, 1991
- Rabbit antibodies against two different extracellular domains of human thyrotropin receptor possess thyroid stimulating activitiesBiochemical and Biophysical Research Communications, 1991
- Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patientsBiochemical and Biophysical Research Communications, 1991
- Role of N-terminal region of the thyrotropin (TSH) receptor in signal transduction for TSH or thyroid stimulating antibodyBiochemical and Biophysical Research Communications, 1991
- Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.Journal of Clinical Investigation, 1991
- Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clonesBiochemical and Biophysical Research Communications, 1990
- Asialoagalacto-Choriongonadotropin, an Antagonist of the Action of Graves' Immunoglobulins in Human Thyroid Membranes with a Limited Affinity for Hepatic ReceptorsHormone and Metabolic Research, 1990
- Protein a from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulinsFEBS Letters, 1972